Regional P&C insurer in the middle of a multi-year turnaround: FY25 ROE 13.7%, combined ratio 94.8%, EPS $4.48; Q1 2026 continued the trend (EPS $1.15, CR 95.6%). After +46% YTD the stock trades at fair value (fwd P/E 10.9x vs peer median ~11x, P/B 1.44x); most of the mean-reversion is already priced. Piper Sandler PT $57 is the bull case; consensus PT $51 (StockAnalysis, Jun 2026) sits below spot. Value factor triggered by fwd P/E <15, but limited residual upside vs cyclical downside from hurricane season.
Methodology: Weighted P/E fair value = 0.20×$66 + 0.50×$53.50 + 0.30×$41 = $53.20 ≈ $54. Implied multiple 11.0x fwd P/E vs peer median 11.4x. Sensitivity: +/-1x multiple = +/-$4.9/sh. Downside anchored by adjusted BV/sh $38.61 (P/B floor ~1x = $38-39). Weights reflect [VALUE] factor with 30% tail risk given cyclical/cat exposure — not built to a target. ⚠️ Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| Core underwriting earnings | $4.90 fwd EPS × 9.5x (peer core CR-adj multiple) | +46.55 |
| Investment portfolio uplift | +15% inv income YoY × $0.30/sh contribution × 8x normalization | +2.40 |
| Dividend + buyback yield | $0.80 div/yr + 2M sh buyback authorization (~7.8% float) capitalized 6x | +3.10 |
| Book value premium/discount | Adj BV $38.61 × 0.05x premium for ROE improvement above peer median | +1.95 |
| Cat/hurricane reserve | Q3 hurricane season expected loss $0.60/sh × 40% probability weighting | −0.24 |
| FV base case | Sum of the rows above | ≈ $53.76 ≈ $54 |
SI <5% = low; UFCS is comfortably in low band. No indication of bearish institutional positioning. Combined with insider net buying and dividend increase, the capital structure signal is unambiguously positive.
| Item | FY2023 | FY2024 | FY2025 | TTM Q1'26 | Guidance 2026E |
|---|---|---|---|---|---|
| Revenue ($M) | 1,116 | 1,254 | 1,386 | 1,420 | ~1,470 |
| Net income ($M) | −16 | 62 | 118 | 131 | ~128 |
| EPS diluted ($) | −0.65 | 2.42 | 4.48 | 4.96 | ~4.90 |
| Combined Ratio % | 107.8 | 101.5 | 94.8 | 94.5 | 94–96 |
| Net written premium ($M) | 1,152 | 1,235 | 1,346 | 1,378 | ~1,470 |
| ROE % | −2.0 | 8.0 | 13.7 | 14.0 | 12–14 |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
| Revenue ($M) | 319 | 343 | 358 | 366 | 369 |
| Combined ratio % | 99.4 | 96.0 | 91.9 | 92.3 | 95.6 |
| EPS diluted ($) | 0.67 | 1.11 | 1.49 | 1.45 | 1.15 |
| Adj. book value/sh ($) | 32.85 | 34.30 | 36.05 | 37.87 | 38.61 |
Business model — Regional P&C insurer with 3 core segments
Core Commercial ~$970M FY26E (66% NWP) 🟢 growing Commercial multi-peril, general liability, workers' comp for SMBs. Q1'26 record NWP, discipline on rate holding. Main earnings engine; sensitive to construction/services cycle. Specialty & Surety ~$310M FY26E (21% NWP) 🟢 growing Excess & surplus lines, marine, professional liability, surety bonds. Higher margin, less competitive; strategic priority of current management. GM target: CR <90%. Personal & Alt Dist. ~$190M FY26E (13% NWP) 🟡 stable Personal auto/home + alternative distribution channels. Smaller run-rate, more exposed to weather losses. Growth via program business partners.
Legal, regulatory and risk analysis
SWOT analysis
- +CR turnaround delivered: 107.8% (FY23) → 94.8% (FY25); Q1'26 CR 95.6% confirms trajectory.
- +FY25 ROE 13.7%, +4.6pp YoY, moving toward peer-leader range.
- +Investment portfolio +15% income YoY; tailwind from higher rates rolling forward.
- +Dividend +25% YoY, 2M share buyback authorized, insider net buying — signals confidence.
- +Beta 0.53 = low correlation to broader market volatility.
- −Sub-scale vs peer group: $1.4B NWP with ~34% expense ratio (peer avg 30%).
- −Limited pricing power in commercial lines vs specialty peers (KNSL, SIGI).
- −Only 2 years of clean underwriting track record — SIGI, KNSL, RLI have 5-10+.
- −No forward EPS guidance from management — implicit only.
- →Specialty & surety segment expansion — higher margins, less competitive.
- →Multiple re-rate to 12-13x fwd P/E if CR stays <95% for 4+ quarters.
- →Alternative distribution channels (program business) as scalable growth vector.
- →Sector consolidation could make UFCS an attractive acquisition target at 1.5-2x book.
- !Q3 2026 hurricane season — one active storm can hit CR by 5-10pts.
- !Commercial rate cycle softening (management flagged in Q1 call).
- !Reserve development risk on long-tail lines (workers' comp, commercial auto).
- !Competitive escalation from larger, better-capitalized peers (WRB, CINF, THG).
Summary by assessment area
- FY25 ROE 13.7%, CR 94.8%, EPS $4.48 (+97% YoY).
- Q1 2026 continued trajectory: EPS $1.15 vs $0.83 consensus.
- Book value/sh $37.06 (+17% YoY).
- Fwd P/E 10.9x vs peer median 11.4x — in line, not cheap.
- P/B 1.44x vs peer 1.35-1.65x — mid-range.
- Consensus PT $51 (−4%); Piper bull PT $57 (+7%).
- Q3 hurricane season = binary risk factor.
- +46% YTD run = elevated technical position.
- Historical bear cases (FY23): −24% year with cat losses.
Sources: MarketBeat (UFCS quote 07/01/2026), StockAnalysis.com (UFCS overview Jun 30, 2026), Macrotrends (UFCS price history), Zacks (Best Small-Cap Stocks Jun 24, 2026), GlobeNewsWire (UFCS Q1 2026 earnings release May 5, 2026), StockTitan (Q1 2026 8-K, 10-Q), SimplyWall.St (UFCS earnings analysis), TheFly/Piper Sandler (analyst PT change May 2026). Market data — last verified close 2026-07-01: UFCS $53.42, market cap ~$1.37B, 52W: $25.79–$53.81, 25.66M shares outstanding. Short interest 1.11%. ⚠️ This document is for informational purposes only and does not constitute financial or investment advice.